phosphonoacetic acid and flucytosine

phosphonoacetic acid has been researched along with flucytosine in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL1
Huber, BE; Wei, K1
Beltinger, C; Buechele, B; Debatin, KM; Simmet, T; Unger, MM; Ushmorov, A; Wahl, J1
Cai, S; Du, J; Jiang, J; Liu, L; Liu, Q; Sung, KL; Yan, X; Yang, L; Yang, Y; Yu, S; Zhang, H1

Other Studies

4 other study(ies) available for phosphonoacetic acid and flucytosine

ArticleYear
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
    PloS one, 2016, Volume: 11, Issue:10

    Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat

2016
Cytosine deaminase gene as a positive selection marker.
    The Journal of biological chemistry, 1996, Feb-16, Volume: 271, Issue:7

    Topics: 3T3 Cells; Animals; Antineoplastic Agents; Apoptosis; Aspartic Acid; Cell Cycle; Cell Division; Cell Line, Transformed; Cell Survival; Culture Media; Cytosine; Cytosine Deaminase; Flucytosine; Gene Expression; Genes, Bacterial; Genetic Markers; Inosine; Mice; Nucleoside Deaminases; Phosphonoacetic Acid; Rats; Transfection; Tumor Cells, Cultured

1996
Enriching suicide gene bearing tumor cells for an increased bystander effect.
    Cancer gene therapy, 2007, Volume: 14, Issue:1

    Topics: Animals; Aspartic Acid; Bystander Effect; Cell Line, Tumor; Cytosine Deaminase; Female; Flucytosine; Genetic Therapy; Mice; Pentosyltransferases; Phosphonoacetic Acid; Plasmids

2007
Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells.
    Experimental cell research, 2010, Dec-10, Volume: 316, Issue:20

    Topics: 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; Adult; Animals; Antigens, CD; Antimetabolites; Aspartic Acid; Bone Marrow Cells; Cell Differentiation; Cell Survival; Cell Transformation, Neoplastic; Cytosine Deaminase; Escherichia coli Proteins; Flucytosine; Gene Expression; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Kruppel-Like Transcription Factors; Lentivirus; Luciferases; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Phosphonoacetic Acid; Promoter Regions, Genetic; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-myc; Response Elements; Stromal Cells; Telomerase; Transduction, Genetic; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays; Young Adult

2010